Clinical Trials Directory

Trials / Completed

CompletedNCT07194720

Effects of the Cornelian Cherry Supplementation on the Selected Physiological Parameters in Marathon Runners

Effects of the Cornelian Cherry (Cornus Mas L.) Lyophilisate Supplementation on the Selected Physiological Parameters in Amateur Long-Distance Runners

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Wroclaw Medical University · Academic / Other
Sex
Male
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

Growing body of evidence indicates favorable effects of Cornus mas (Cornelian cherry) supplements on cardiometabolic risk, including the improvement of HDL and glycemic indices, in line with vascular benefits. Experimental data feature bioactives from Cornelian cherry as potential modulators of vascular function and blood pressure, plausibly via endothelial nitric oxide-related pathways, with possible downstream effects on autonomic reflex control; nevertheless, such links in humans remain poorly explored to date, especially in terms of endurance training and hypoxia tolerance. In this cross-over, placebo-controlled study, a group of healthy amateur long-distance runners underwent two stages of a four-week dietary intervention (separated by four weeks of washout period), receiving Cornelian cherry lyophilisate or placebo. Each supplementation stage was accompanied by the comprehensive evaluation of the cardio-respiratory parameters and endothelial function.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCornus mas lyophilisateParticipants receiving a Cornus mas (Cornelian cherry) lyophilisate for 4 weeks.
DIETARY_SUPPLEMENTPlaceboParticipants receiving a starch- and sugar-based placebo for 4 weeks.

Timeline

Start date
2021-09-15
Primary completion
2022-04-21
Completion
2022-04-21
First posted
2025-09-26
Last updated
2025-10-01

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07194720. Inclusion in this directory is not an endorsement.